| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 489 | 261 | 13 |
| Full Text Views | 5 | 1 | 0 |
| PDF Downloads | 2 | 2 | 0 |
Antibiotic Synergism in Amebiasis
Hamilton H. Anderson
Hamilton H. Anderson
Department of Pharmacology and Experimental Therapeutics, and the Department of Pediatrics, School of Medicine, University of California, Sonoma State Hospital, San Francisco
Search for other papers by Hamilton H. Anderson in
Current site
Google Scholar
PubMed
Search for other papers by Hamilton H. Anderson in
Current site
Google Scholar
PubMed
Thomas L. Nelson
Thomas L. Nelson
Department of Pharmacology and Experimental Therapeutics, and the Department of Pediatrics, School of Medicine, University of California, Sonoma State Hospital, San Francisco
Search for other papers by Thomas L. Nelson in
Current site
Google Scholar
PubMed
Search for other papers by Thomas L. Nelson in
Current site
Google Scholar
PubMed
Arseny K. Hrenoff
Arseny K. Hrenoff
Department of Pharmacology and Experimental Therapeutics, and the Department of Pediatrics, School of Medicine, University of California, Sonoma State Hospital, San Francisco
Search for other papers by Arseny K. Hrenoff in
Current site
Google Scholar
PubMed
Search for other papers by Arseny K. Hrenoff in
Current site
Google Scholar
PubMed
Charles H. Fish
Charles H. Fish
Department of Pharmacology and Experimental Therapeutics, and the Department of Pediatrics, School of Medicine, University of California, Sonoma State Hospital, San Francisco
Search for other papers by Charles H. Fish in
Current site
Google Scholar
PubMed
Search for other papers by Charles H. Fish in
Current site
Google Scholar
PubMed
Summary
After suggestive studies in vitro and trials in 49 macaques, 52 episodes of amebic infection in mentally defective children were treated with erythromycin alone, with fumagillin alone, and with these antibiotics in combination. Two recurrences of 17 treated cases were noted after erythromycin therapy, 5 of 21 after the two antibiotics were given concurrently, and 6 of 14 after fumagillin was given alone. The final test regimes followed by the 13 human patients whose infection recurred, provided clearance for all but one of the original group of patients having E. histolytica infection.
Author Notes
With the technical assistance of Ruth M. McElroy, Jeanette Van D. Anderson and Dorothy Swanman. Supported, in part, by the National Institutes of Health, Bethesda, Maryland and The Abbott Laboratories, North Chicago, Illinois (studies in man) and the Upjohn Laboratories, Kalamazoo, Michigan (studies in macaques).
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 489 | 261 | 13 |
| Full Text Views | 5 | 1 | 0 |
| PDF Downloads | 2 | 2 | 0 |